NCT02740049View on ClinicalTrials.gov

In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 27, 2016

Primary Completion Date

October 19, 2016

Study Completion Date

October 19, 2016

Conditions
Asthma
Interventions
DRUG

VR588

Evaluation of the efficacy of a novel JAK/STAT inhibitor, VR588, in isolated epithelial cells from asthma patients

Trial Locations (1)

SW3 6NP

Royal Brompton & Harefield NHS Foundation Trust, London

All Listed Sponsors
collaborator

Vectura Limited

INDUSTRY

lead

Imperial College London

OTHER

NCT02740049 - In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma | Biotech Hunter | Biotech Hunter